Dainippon Sumitomo Pharma Co said on Wednesday it will buy US bio-venture Boston Biomedical Inc. for $200 million.
41423
Dainippon Sumitomo Pharma to buy US bio-venture
66069
Targacept publicly offering 2.2 million shares
59990
Boston Scientific completes sale of Cardiac Surgery and Vascular Surgery businesses
112856
Drug company paying nh $1.2 million
175964
Bed Bath & Beyond to acquire Cost Plus
79744
Boston Scientific receives approval
73563
Valeant Pharmaceuticals to acquire iNova
19743
Boston Scientific assigned patent for drug delivery
12812
Cleveland BioLabs (cbli) announces offering by selling shareholders
174709
Danaher to acquire Beckman Coulter
32474
GlaxoSmithKline to acquire Sirtris Pharmaceuticals
143854
MedAssets completes acquisition of
144538
McKesson completes acquisition of US Oncology
42569
DDB Worldwide announces the acquisition of Synergy
22291
DTS to acquire SRS Labs
53167
BMC to buy BladeLogic for about $800 million
41320
LabCorp strikes deal for Alzheimer's disease diagnostic